Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    August 2021
  1. HUG L, You D, Blencowe H, Mishra A, et al
    Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment.
    Lancet. 2021;398:772-785.
    >> Share

  2. ODENDAAL J, Quenby S
    Making miscarriage matter - Authors' reply.
    Lancet. 2021;398:745-746.
    >> Share

  3. AGAMPODI S, Hettiarachchi A, Agampodi T
    Making miscarriage matter.
    Lancet. 2021;398:745.
    >> Share

  4. LUCAS S, Knight M, Lucas N, Rodger A, et al
    Making miscarriage matter.
    Lancet. 2021;398:744-745.
    >> Share

  5. CHONG K, Li W, Roberts I, Mol BW, et al
    Making miscarriage matter.
    Lancet. 2021;398:743-744.
    >> Share

  6. KIGULI J, Kirunda R, Nabaliisa J, Nalwadda CK, et al
    Inadequate evidence on stillbirths: rethinking public health.
    Lancet. 2021;398:727-729.
    >> Share

  7. KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
    SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
    >> Share

  8. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    >> Share

  9. MIANI C, Razum O
    The fragility of abortion access in Europe: a public health crisis in the making.
    Lancet. 2021;398:485.
    >> Share

    July 2021
  10. WARASNA B, Rajabi N, Mustafa B, Najjar A, et al
    Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study.
    Lancet. 2021;398 Suppl 1:S45.
    >> Share

  11. ISBEIH M, Venkateswaran M, Abbas E, Abu-Khader K, et al
    Gestational age recorded at delivery versus estimations using antenatal care data from the Electronic Maternal and Child Health Registry in the West Bank: a comparative analysis.
    Lancet. 2021;398 Suppl 1:S31.
    >> Share

    Effect of hypertension on pregnancy outcomes at UNRWA health centres in Gaza governorates: a comparative study.
    Lancet. 2021;398 Suppl 1:S26.
    >> Share

  13. BOGALE B, Morkrid K, O'Donnell B, Ghanem B, et al
    Development of a targeted client communication intervention for pregnant and post-partum women: a descriptive study.
    Lancet. 2021;398 Suppl 1:S18.
    >> Share

    May 2021
  14. CHAPPELL LC, Cluver CA, Kingdom J, Tong S, et al
    Lancet. 2021 May 27. pii: S0140-6736(20)32335.
    >> Share

  15. MENON U, Gentry-Maharaj A, Burnell M, Singh N, et al
    Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
    Lancet. 2021 May 12. pii: S0140-6736(21)00731.
    >> Share

  16. HURWITZ LM, Pinsky PF, Trabert B
    General population screening for ovarian cancer.
    Lancet. 2021 May 12. pii: S0140-6736(21)01061.
    >> Share

    April 2021
    Miscarriage: worldwide reform of care is needed.
    Lancet. 2021 Apr 26. pii: S0140-6736(21)00954.
    >> Share

  18. COOMARASAMY A, Dhillon-Smith RK, Papadopoulou A, Al-Memar M, et al
    Recurrent miscarriage: evidence to accelerate action.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00681.
    >> Share

  19. COOMARASAMY A, Gallos ID, Papadopoulou A, Dhillon-Smith RK, et al
    Sporadic miscarriage: evidence to provide effective care.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00683.
    >> Share

  20. QUENBY S, Gallos ID, Dhillon-Smith RK, Podesek M, et al
    Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00682.
    >> Share

  21. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    >> Share

  22. LOCKMAN S, Brummel SS, Ziemba L, Stranix-Chibanda L, et al
    Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAA
    Lancet. 2021;397:1276-1292.
    >> Share

  23. GILLEECE Y, Krankowska D
    ART in pregnant women living with HIV.
    Lancet. 2021;397:1240-1241.
    >> Share

    February 2021
  24. TAYLOR HS, Kotlyar AM, Flores VA
    Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.
    Lancet. 2021;397:839-852.
    >> Share

    January 2021
  25. BOOTH A
    Honduras changes constitution to ban abortion.
    Lancet. 2021;397:360.
    >> Share

  26. LHEUREUX S, Cristea MC, Bruce JP, Garg S, et al
    Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2021;397:281-292.
    >> Share

  27. BLAGDEN SP, Nicum S
    A source of hope for platinum-resistant ovarian cancer?
    Lancet. 2021;397:254-256.
    >> Share

  28. BOOTH A
    Argentina to legalise elective abortion.
    Lancet. 2021;397:82.
    >> Share

    December 2020
  29. CLARKE C
    Abortion and The Lancet's call to arms.
    Lancet. 2020;394:2241.
    >> Share

    November 2020
  30. GILBERT L, Miller K, Medeiros D, Tsatoumas M, et al
    A disease disregards anatomical planes: actinomycosis and an intrauterine device.
    Lancet. 2020;396:1766.
    >> Share

  31. CAMERON ST, Glasier A, McDaid L, Radley A, et al
    Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
    Lancet. 2020;396:1585-1594.
    >> Share

  32. MARSTON C, Sowemimo A
    Bridge-It trial-a step towards better contraception services.
    Lancet. 2020;396:1536-1537.
    >> Share

    September 2020
  33. ALVES L
    Brazilian doctors condemn new rules on abortion.
    Lancet. 2020;396:808.
    >> Share

  34. SHAHAR-NISSAN K, Pardo J, Peled O, Krause I, et al
    Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;396:779-785.
    >> Share

  35. LEVY L, Meuwly JY, Sarivalasis A, Achtari C, et al
    Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
    Lancet. 2020;396:725.
    >> Share

  36. EVANS DK, Acosta AM
    Lifting bans on pregnant girls in school.
    Lancet. 2020;396:667-668.
    >> Share

    August 2020
  37. DASHRAATH P, Nielsen-Saines K, Madhi SA, Baud D, et al
    COVID-19 vaccines and neglected pregnancy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31822.
    >> Share

  38. CHU JJ, Devall AJ, Beeson LE, Hardy P, et al
    Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31788.
    >> Share

    Medical management of miscarriage with mifepristone.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31789.
    >> Share

  40. VON DADELSZEN P, Bhutta ZA, Sharma S, Bone J, et al
    The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis.
    Lancet. 2020;396:553-563.
    >> Share

  41. POUCHOT J, Couprie A
    A wandering spleen, splenomegaly, hypersplenism, and iron deficiency anaemia.
    Lancet. 2020;396:412.
    >> Share

  42. CROVETTO F, Crispi F, Llurba E, Figueras F, et al
    Seroprevalence and presentation of SARS-CoV-2 in pregnancy.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31714.
    >> Share

  43. MAEDA Y, Ogawa K, Kamihara Y, Tanimoto T, et al
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:308.
    >> Share

  44. CHAPPELL LC, Juszczak E, Shennan A
    Managing late preterm pre-eclampsia - Authors' reply.
    Lancet. 2020;396:308-309.
    >> Share

    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:307-308.
    >> Share

    July 2020
  46. JAFFE S
    US Supreme Court upholds abortion rights, for now.
    Lancet. 2020;396:85-86.
    >> Share

  47. CLUVER CA, Herbst P, Griffith-Richards S, Hassan M, et al
    Coarctation of the aorta: a rare cause of severe hypertension in pregnancy.
    Lancet. 2020;396:62.
    >> Share

    US Global Gag Rule increases unsafe abortion.
    Lancet. 2020;396:24-25.
    >> Share

  49. GINSBURG O, Horton R
    A Lancet Commission on women and cancer.
    Lancet. 2020;396:11-13.
    >> Share

    June 2020
  50. ALLEN S, Cortina CS
    An unusual cause of breast hypertrophy: pseudoangiomatous stromal hyperplasia secondary to contraceptive implant.
    Lancet. 2020;395:1937.
    >> Share

  51. LADHANI SN, Lucidarme J, Parikh SR, Campbell H, et al
    Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis.
    Lancet. 2020;395:1865-1877.
    >> Share

    May 2020
  52. WHITEHEAD CL, Walker SP
    Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Lancet. 2020 May 13. pii: S0140-6736(20)31029.
    >> Share

    April 2020
  53. PANCHAUD A, Favre G, Pomar L, Vouga M, et al
    An international registry for emergent pathogens and pregnancy.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30981.
    >> Share

    March 2020
  54. CHEN H, Guo J, Wang C, Luo F, et al
    Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
    Lancet. 2020;395:809-815.
    >> Share

  55. QIAO J
    What are the risks of COVID-19 infection in pregnant women?
    Lancet. 2020;395:760-762.
    >> Share

  56. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    >> Share

    February 2020
  57. BURKI T
    UNAIDS and IAEA join forces on HIV and cervical cancer.
    Lancet. 2020;395:484.
    >> Share

    Appropriate care for pregnant women in Ebola outbreaks.
    Lancet. 2020;395:468.
    >> Share

    Preventing teenage pregnancies in Brazil.
    Lancet. 2020;395:468.
    >> Share

  60. TANIGUCHI Y, Nishikawa H, Maeda N, Terada Y, et al
    Breathlessness, pleural effusions, fibromas, and Meigs syndrome: look beyond the chest and don't delay!
    Lancet. 2020;395:e32.
    >> Share

  61. FAVRE G, Pomar L, Musso D, Baud D, et al
    2019-nCoV epidemic: what about pregnancies?
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30311.
    >> Share

    Eliminating cervical cancer.
    Lancet. 2020;395:312.
    >> Share

    No global consensus among doctors or society on abortion.
    Lancet. 2020;395:e17.
    >> Share

  64. DUHIG K, Myers J, Seed PT, Shennan AH, et al
    Placental growth factor testing in suspected pre-eclampsia - Authors' reply.
    Lancet. 2020;395:336-337.
    >> Share

  65. KERMACK AJ, Stocker LJ, Coleman M
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335-336.
    >> Share

  66. TANNER M, Mol BW
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335.
    >> Share

  67. PHUMAPHI J, Gautam KC, Mason E
    Increased production and comprehensive guidelines needed for HPV vaccine.
    Lancet. 2020;395:319-321.
    >> Share

    January 2020
  68. CANFELL K, Kim JJ, Brisson M, Keane A, et al
    Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30157.
    >> Share

  69. BRISSON M, Kim JJ, Canfell K, Drolet M, et al
    Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30068.
    >> Share

  70. TSU VD
    Cervical cancer elimination: are targets useful?
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30219.
    >> Share

  71. HOFFMAN MK, Goudar SS, Kodkany BS, Metgud M, et al
    Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:285-293.
    >> Share

  72. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    >> Share

  73. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    >> Share

    November 2019
    Dolutegravir: advancing ethical research in pregnancy.
    Lancet. 2019;394:1972-1974.
    >> Share

  75. CLAMP AR, James EC, McNeish IA, Dean A, et al
    Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32259.
    >> Share

  76. ESKANDER RN, Monk BJ
    Moving beyond cytotoxic drug dosing in ovarian cancer.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32948.
    >> Share

  77. CERDEIRA AS, Tome M, Moore N, Lim L, et al
    Seeing red degeneration in uterine fibroids in pregnancy: proceed with caution.
    Lancet. 2019;394:e37.
    >> Share

    October 2019
  78. O'NEILL D
    Abortion as a moral good?
    Lancet. 2019;394:1323-1324.
    >> Share

  79. MILLER D
    Hyaluronan-selected sperm should not be considered an add-on - Author's reply.
    Lancet. 2019;394:1320.
    >> Share

    Hyaluronan-selected sperm should not be considered an add-on.
    Lancet. 2019;394:1319-1320.
    >> Share

    September 2019
  81. SUGIMURA K, Sasaki O, Shinoda M, Kawasaki S, et al
    Catamenial pneumothorax: a cause of monthly breathlessness.
    Lancet. 2019;394:952.
    >> Share

  82. SINGH S, Bougie O
    HEALTH for heavy menstrual bleeding: real-world implications.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)32086.
    >> Share

  83. COOPER K, Breeman S, Scott NW, Scotland G, et al
    Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)31790.
    >> Share

    August 2019
    Menopausal hormones: definitive evidence for breast cancer.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31901.
    >> Share

  85. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    >> Share

  86. BERAL V, Peto R, Pirie K, Reeves G, et al
    Menopausal hormone therapy and 20-year breast cancer mortality.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)32033.
    >> Share

  87. CHAPPELL LC, Brocklehurst P, Green ME, Hunter R, et al
    Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31963.
    >> Share

  88. STAFF AC
    Long-term cardiovascular health after stopping pre-eclampsia.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31993.
    >> Share

    Prepregnancy calcium supplementation and pre-eclampsia - Author's reply.
    Lancet. 2019;394:e8.
    >> Share

  90. MAEDA Y, Suzuki Y, Yamamoto K, Tanimoto T, et al
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e7.
    >> Share

  91. PONZETTO A, Figura N, Riva P
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e6.
    >> Share

  92. HAIGH A, Haigh K
    Coroners' investigations of stillbirths.
    Lancet. 2019;394:564.
    >> Share

  93. LEMOINE ER, Karumanchi SA
    Oral regimen management of acute hypertension in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31717.
    >> Share

  94. CHAPPELL LC, Bell JL, Smith A, Linsell L, et al
    Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31270.
    >> Share

  95. EASTERLING T, Mundle S, Bracken H, Parvekar S, et al
    Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31282.
    >> Share

    Ursodeoxycholic acid for intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31607.
    >> Share

    July 2019
  97. BURKI T
    Northern Ireland likely to legalise abortion.
    Lancet. 2019;394:290.
    >> Share

  98. HEMIDA R, van Doorn HC
    Avoid making a mountain out of an invasive hydatidiform mole: do a pregnancy test!
    Lancet. 2019;394:e2.
    >> Share

    Hysterectomies in Beed district raise questions for India.
    Lancet. 2019;394:202.
    >> Share

    June 2019
  100. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    >> Share

  101. DROLET M, Benard E, Perez N, Brisson M, et al
    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30298.
    >> Share

  102. SMIT JG
    Ongoing pregnancy as the primary outcome for the inSIGHT study.
    Lancet. 2019;393:2389.
    >> Share

  103. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Lancet. 2019 Jun 13. pii: S0140-6736(19)31288.
    >> Share

    May 2019
    We must all support women in the fight for abortion.
    Lancet. 2019;393:2099.
    >> Share

  105. JAFFE S
    Legal battles over abortion heat up in the USA.
    Lancet. 2019;393:1923-1924.
    >> Share

  106. LI A
    Northern Ireland deadlock impedes abortion rights progress.
    Lancet. 2019;393:1794.
    >> Share

  107. BUJOLD E, Chaillet N, Kingdom J
    Placental growth factor testing for suspected pre-eclampsia.
    Lancet. 2019;393:1775-1776.
    >> Share

  108. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    >> Share

  109. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    >> Share

    April 2019
    Progress on investigating stillbirths.
    Lancet. 2019;393:1386.
    >> Share

  111. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
    Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
    >> Share

    March 2019
    Gestational diabetes in England: cause for concern.
    Lancet. 2019;393:1262.
    >> Share

  113. WEI D, Liu JY, Sun Y, Shi Y, et al
    Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.
    Lancet. 2019;393:1310-1318.
    >> Share

  114. LHEUREUX S, Gourley C, Vergote I, Oza AM, et al
    Epithelial ovarian cancer.
    Lancet. 2019;393:1240-1253.
    >> Share

  115. WATSON K
    Abortion as a moral good.
    Lancet. 2019;393:1196-1197.
    >> Share

  116. LAUFER MK
    Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32615.
    >> Share

  117. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
    Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
    >> Share

  118. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    >> Share

    February 2019
    Interpregnancy interval after stillbirth: modifiable, but does it matter?
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32430.
    >> Share

  120. REGAN AK, Gissler M, Magnus MC, Haberg SE, et al
    Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study.
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32266.
    >> Share

  121. KIOKO PM, Meana PR
    Abortion in Argentina.
    Lancet. 2019;393:745.
    >> Share

  122. GARCIA G
    Abortion in Argentina.
    Lancet. 2019;393:744.
    >> Share

    Abortion in Argentina.
    Lancet. 2019;393:744-745.
    >> Share

  124. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
    Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
    >> Share

  125. PALMER KR, Xiaohua L, Mol BW
    Management of intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
    >> Share

  126. REPPING S
    Evidence-based medicine and infertility treatment.
    Lancet. 2019;393:380-382.
    >> Share

  127. MILLER D, Pavitt S, Sharma V, Forbes G, et al
    Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial.
    Lancet. 2019;393:416-422.
    >> Share

    January 2019
  128. HOFMEYR GJ, Betran AP, Singata-Madliki M, Cormick G, et al
    Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2019;393:330-339.
    >> Share

  129. BUJOLD E, Hyett J
    Calcium supplementation for prevention of pre-eclampsia.
    Lancet. 2019;393:298-300.
    >> Share

  130. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
    Cervical cancer.
    Lancet. 2019;393:169-182.
    >> Share

    Cervical cancer: unequal progress.
    Lancet. 2019;393:104.
    >> Share

    December 2018
  132. BERNITZ S, Dalbye R, Zhang J, Eggebo TM, et al
    The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial.
    Lancet. 2018 Dec 20. pii: S0140-6736(18)31991.
    >> Share

  133. DIAZ-GARCIA C, Pellicer A
    Uterus transplantation from a deceased donor.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32106.
    >> Share

  134. EJZENBERG D, Andraus W, Baratelli Carelli Mendes LR, Ducatti L, et al
    Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)31766.
    >> Share

    November 2018
    Addressing preventable stillbirth and brain injury.
    Lancet. 2018;392:2238.
    >> Share

    October 2018
    Unexplained infertility - Authors' reply.
    Lancet. 2018;392:1517.
    >> Share

  137. GLEICHER N, Kuhnir VA, Barad DH
    Unexplained infertility.
    Lancet. 2018;392:1516-1517.
    >> Share

  138. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    >> Share

  139. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    >> Share

  140. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    >> Share

  141. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    >> Share

    September 2018
  142. TEMMERMAN M, Lawn JE
    Stillbirths count, but it is now time to count them all.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)32342.
    >> Share

  143. SMITH LK, Hindori-Mohangoo AD, Delnord M, Durox M, et al
    Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)31651.
    >> Share

    August 2018
  144. GRESSLER LE, Titus-Glover D, Shaya FT
    Treatment modalities for pregnant women with opioid use disorder.
    Lancet. 2018;392:551.
    >> Share

  145. SEN A, Nashef L
    New regulations to cut valproate-exposed pregnancies.
    Lancet. 2018;392:458-460.
    >> Share

    July 2018
  146. GHOSN J, Taiwo B, Seedat S, Autran B, et al
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
    >> Share

    Cervical cancer prevention in Thailand-a model of success.
    Lancet. 2018;392:2.
    >> Share

    June 2018
  148. LI A
    From Ireland to Northern Ireland: campaigns for abortion law.
    Lancet. 2018;391:2403-2404.
    >> Share

  149. BOOTH A
    Argentina votes on bill to legalise abortion up to 14 weeks.
    Lancet. 2018;391:e21-e22.
    >> Share

    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    >> Share

    May 2018
    Abortion narratives: moving from statistics to stories.
    Lancet. 2018 May 8. pii: S0140-6736(18)31036.
    >> Share

  152. SPERBER A
    El Salvador's total ban on abortion risks women's health.
    Lancet. 2018;391:1758-1759.
    >> Share

    April 2018
  153. BARNETT R
    Lancet. 2018;391:1471.
    >> Share

    March 2018
    Diagnosis of heavy menstrual bleeding: a change in direction.
    Lancet. 2018;391:1122.
    >> Share

    Abortion: access and safety worldwide.
    Lancet. 2018;391:1121.
    >> Share

  156. WATTS G
    New York Challenge sets high bar for HPV vaccination.
    Lancet. 2018;391:1137.
    >> Share

    February 2018
  157. MUSALLAM R, Salem N, Al Halol R, Al Deeb H, et al
    Management of pregnancy loss in the first trimester: a retrospective audit.
    Lancet. 2018;391 Suppl 2:S34.
    >> Share

  158. HABABEH M, Zeidan W, El-Kader MA, Thaher AA, et al
    Contraceptive use by Palestine refugee mothers of young children attending UNRWA clinics: a cross-sectional follow-up study.
    Lancet. 2018;391 Suppl 2:S26.
    >> Share

  159. KATEEB E, Momany E
    Factors related to high dental caries experience in Palestinian pregnant women in the Jerusalem governorate: a cross-sectional study.
    Lancet. 2018;391 Suppl 2:S11.
    >> Share

  160. LARSON HJ
    A global girl gang.
    Lancet. 2018;391:527-528.
    >> Share

  161. DEVI S
    FGM in Sierra Leone.
    Lancet. 2018;391:415.
    >> Share

    December 2017
  162. WEISS NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, et al
    Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.
    Lancet. 2017 Dec 19. pii: S0140-6736(17)33308.
    >> Share

  163. CAHILL N, Sonneveldt E, Stover J, Weinberger M, et al
    Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33104.
    >> Share

  164. KVASKOFF M, Horne AW, Missmer SA
    Informing women with endometriosis about ovarian cancer risk.
    Lancet. 2017;390:2433-2434.
    >> Share

    November 2017
  165. GHORANI E, Kaur B, Fisher RA, Short D, et al
    Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
    Lancet. 2017;390:2343-2345.
    >> Share

  166. NANDI A, El-Toukhy T
    Stimulated intrauterine insemination for unexplained subfertility.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)33038.
    >> Share

  167. FARQUHAR CM, Liu E, Armstrong S, Arroll N, et al
    Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)32406.
    >> Share

  168. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
    Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
    >> Share

  169. MABEY D, Marks M, Peeling R, Lawn J, et al
    Stillbirth caused by syphilis remains a major global health problem.
    Lancet. 2017;390:2036.
    >> Share

    Syphilis in children.
    Lancet. 2017;390:2035-2036.
    >> Share

    October 2017
  171. REGAN L, Glasier A
    The British 1967 Abortion Act-still fit for purpose?
    Lancet. 2017;390:1936-1937.
    >> Share

  172. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    >> Share

    September 2017
    Contraception implant removed from global market.
    Lancet. 2017;390:1576.
    >> Share

    Estimating abortion safety: advancements and challenges.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)32135.
    >> Share

  175. GANATRA B, Gerdts C, Rossier C, Johnson BR Jr, et al
    Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)31794.
    >> Share

  176. GARG SK, Polsky S
    Continuous glucose monitoring in pregnant women with type 1 diabetes.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
    >> Share

  177. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
    Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
    >> Share

  178. DIZON DS
    PARP inhibitors for targeted treatment in ovarian cancer.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32418.
    >> Share

  179. COLEMAN RL, Oza AM, Lorusso D, Aghajanian C, et al
    Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32440.
    >> Share

  180. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    >> Share

  181. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    >> Share

    July 2017
    Bevacizumab in cervical cancer: a step forward for survival.
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
    >> Share

  183. TEWARI KS, Sill MW, Penson RT, Huang H, et al
    Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
    >> Share

    April 2017
    Syphilis: an ancient disease in a modern era.
    Lancet. 2017;389:1492.
    >> Share

    December 2016
  185. HOOK EW RD
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016